The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Payment of Additional Director Fees

25 Apr 2022 08:45

RNS Number : 1826J
CIP Merchant Capital Ltd
25 April 2022
 

 

25 April 2022

 

CIP MERCHANT CAPITAL LIMITED

("CIP" or the "Company")

 

Payment of Additional Director Fees

 

The Board of CIP announces that it has agreed to make a one-off additional payment of, in aggregate, £57,500, to the Company's directors in connection with the additional work undertaken by the Board, beyond the scope of their existing contractual arrangements with the Company, in relation to addressing Corporation Financière Européenne S.A.'s ("CFE") protracted stake building, announcement of a possible offer for CIP, and subsequent hostile offer for CIP, over the past 18 months (the "Additional Director Fees").

 

The Additional Director Fees are to be paid as follows:

 

Director

Additional Director Fees

Adrian Collins

£17,500

John Falla

£15,000

Robert King

£12,500

Piero Sansalone

£12,500

 

 

Related Party Transaction

 

The payment of the Additional Director Fees is deemed to be a related party transaction under the AIM Rules. Due to the participation of all of the Company's directors, there is no director independent of the Additional Director Fees arrangement to provide the necessary AIM Rule 13 related party transaction opinion.

 

Accordingly, Strand Hanson Limited, the Company's Nominated Adviser, is satisfied that the Additional Director Fees are fair and reasonable, insofar as the Shareholders are concerned.

 

 

Enquiries:

 

CIP Merchant Capital Limited

Wikus van Schalkwyk

 

+44 1481 749363

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

Stuart Faulkner / Matthew Chandler / James Bellman / Rob Patrick

+44 20 7409 3494

 

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (which applies in the United Kingdom by operation of the European Union (Withdrawal) Act 2018 (as amended)). The person responsible for arranging release of this announcement on behalf of CIP is Adrian Collins.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDELBLLZLXBBV
Date   Source Headline
17th Feb 20227:00 amRNSPartial Divestment of interest in Alkemy SpA
16th Feb 20227:00 amRNSForm 8.3 - CIP Merchant Capital Limited
15th Feb 20227:00 amRNSNet Asset Value(s)
14th Feb 202210:30 amRNSPublication of Defence Circular
11th Feb 20228:52 amRNSForm 8.3 - CIP Merchant Capital Limited
9th Feb 20229:39 amRNSForm 8.3 - CIP Merchant Capital Limited
8th Feb 20228:46 amRNSForm 8.3 - CIP Merchant Capital Ltd.
8th Feb 20227:00 amRNSNet Asset Value(s)
7th Feb 20228:34 amRNSForm 8.3 - CIP Merchant Capital Limited
4th Feb 202210:01 amRNSForm 8.3 - CIP Merchant Capital Limited
3rd Feb 20221:59 pmRNSForm 8.3 - CIP MERCHANT CAPITAL LIMITED
3rd Feb 20229:45 amRNSForm 8.3 - CIP Merchant Capital Ltd.
2nd Feb 202210:53 amRNSForm 8.3 - CIP Merchant Capital Limited
2nd Feb 20229:29 amRNSForm 8.3 - CIP Merchant Capital Ltd
1st Feb 20227:00 amRNSNet Asset Value(s)
31st Jan 202212:57 pmRNSForm 8.3 - CIP Merchant Capital Ltd
31st Jan 20229:06 amRNSStatement re Publication of CFE’s Mandatory Offer
31st Jan 20227:15 amRNSPosting of Offer Document
28th Jan 20226:05 pmRNSForm 8.3 - CIP Merchant Capital Ltd
28th Jan 202210:18 amRNSForm 8.3 - CIP Merchant Capital Limited
27th Jan 20224:34 pmRNSForm 8 (OPD) - CIP Merchant Capital Limited
27th Jan 20227:00 amRNSUnanimous Rejection of CFE’s Mandatory Cash Offer
26th Jan 202211:02 amRNSFurther Investment in Time Out Group plc
26th Jan 202210:14 amRNSForm 8.3 - C I P MERCHANT CAPITAL
26th Jan 20229:43 amRNSForm 8.3 - CIP Merchant Capital Limited
25th Jan 20229:51 amRNSForm 8.3 - CIP Merchant Capital Limited
25th Jan 20227:00 amRNSNet Asset Value(s)
24th Jan 202210:07 amRNSForm 8.3 - CIP Merchant Capital Limited
21st Jan 20228:48 amRNSForm 8.3 - CIP Merchant Capital Limited
20th Jan 20228:40 amRNSForm 8.3 - CIP Merchant Capital Limited
20th Jan 20227:00 amRNSForm 8 (OPD) - CIP Merchant Capital Limited
19th Jan 202210:28 amRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20221:00 pmRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20229:48 amRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20227:00 amRNSNet Asset Value(s)
17th Jan 20227:00 amRNSResponse to Mandatory Cash Offer by CFE
17th Jan 20227:00 amRNSForm 8 (DD) - CIP Merchant Capital
14th Jan 20224:25 pmRNSOffer for CIP Merchant Capital Limited
11th Jan 20227:00 amRNSNet Asset Value(s)
5th Jan 20229:13 amRNSNet Asset Value(s)
30th Dec 20217:00 amRNSNet Asset Value(s)
29th Dec 20217:00 amRNSHolding(s) in Company
23rd Dec 20214:18 pmRNSInvestment in Aleva Neurotherapeutics SA
21st Dec 20217:00 amRNSNet Asset Value(s)
15th Dec 20214:02 pmRNSHolding(s) in Company
15th Dec 20217:00 amRNSInvestment in Time Out Group
14th Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20219:30 amRNSHolding in Company
9th Dec 20219:08 amRNSDivestment of Vertu Motors plc
7th Dec 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.